Janney Montgomery Scott’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$44M Buy
185,309
+8,403
+5% +$1.75M 0.09% 234
2026
Q1
$37.4M Sell
176,906
-19,379
-10% -$4.17M 0.09% 218
2025
Q4
$40.3M Sell
196,285
-1,010
-0.5% -$190K 0.09% 215
2025
Q3
$31M Sell
197,295
-7,503
-4% -$1.16M 0.07% 259
2025
Q2
$34.4M Sell
204,798
-32,421
-14% -$4.81M 0.09% 221
2025
Q1
$32.7M Sell
237,219
-13,806
-5% -$1.76M 0.09% 216
2024
Q4
$29.7M Buy
251,025
+11,923
+5% +$1.39M 0.08% 233
2024
Q3
$26.4M Buy
239,102
+4,209
+2% +$440K 0.07% 272
2024
Q2
$23.1M Sell
234,893
-21,893
-9% -$2.23M 0.07% 281
2024
Q1
$28.7M Sell
256,786
-21,190
-8% -$2.29M 0.09% 238
2023
Q4
$28M Buy
+277,976
New +$27.6M 0.09% 220
2023
Q3
Sell
-290,369
Closed -$27.5M 2587
2023
Q2
$27.5M Sell
290,369
-11,004
-4% -$929K 0.1% 205
2023
Q1
$22.8M Sell
301,373
-14,130
-4% -$1.07M 0.09% 205
2022
Q4
$24.3M Buy
315,503
+6,101
+2% +$464K 0.09% 209
2022
Q3
$20.6M Buy
309,402
+14,058
+5% +$891K 0.09% 226
2022
Q2
$15.7M Sell
295,344
-3,239
-1% -$184K 0.07% 259
2022
Q1
$16.9M Buy
298,583
+52,470
+21% +$2.81M 0.07% 248
2021
Q4
$12.7M Buy
246,113
+17,445
+8% +$856K 0.05% 328
2021
Q3
$11.3M Buy
228,668
+19,179
+9% +$1.04M 0.05% 333
2021
Q2
$12M Buy
209,489
+19,036
+10% +$1.11M 0.05% 323
2021
Q1
$11.6M Buy
190,453
+13,374
+8% +$738K 0.06% 300
2020
Q4
$9.48M Buy
177,079
+16,215
+10% +$841K 0.05% 342
2020
Q3
$7.55M Buy
160,864
+27,637
+21% +$1.42M 0.04% 362
2020
Q2
$6.95M Buy
133,227
+83,305
+167% +$4.29M 0.04% 360
2020
Q1
$2.39M Buy
49,922
+19,510
+64% +$1.01M 0.02% 624
2019
Q4
$1.54M Sell
30,412
-6,068
-17% -$313K 0.01% 889
2019
Q3
$1.72M Buy
36,480
+7,817
+27% +$357K 0.01% 827
2019
Q2
$1.35M Buy
28,663
+7,910
+38% +$365K 0.01% 901
2019
Q1
$999K Sell
20,753
-2,786
-12% -$140K 0.01% 1026
2018
Q4
$1.05M Sell
23,539
-3,643
-13% -$190K 0.01% 899
2018
Q3
$1.47M Buy
27,182
+702
+3% +$35.9K 0.01% 831
2018
Q2
$1.29M Buy
26,480
+2,095
+9% +$119K 0.01% 859
2018
Q1
$1.53M Sell
24,385
-1,167
-5% -$80.1K 0.02% 777
2017
Q4
$1.57M Sell
25,552
-32,860
-56% -$2.03M 0.02% 755
2017
Q3
$3.91M Buy
58,412
+8,805
+18% +$622K 0.04% 403
2017
Q2
$3.87M Buy
49,607
+14,228
+40% +$1.07M 0.05% 382
2017
Q1
$2.88M Buy
35,379
+9,579
+37% +$754K 0.04% 441
2016
Q4
$1.86M Sell
25,800
-695
-3% -$50.2K 0.03% 528
2016
Q3
$2.06M Buy
+26,495
New +$2.14M 0.04% 428
2016
Q2
Sell
-20,657
Closed -$1.69M 735
2016
Q1
$1.69M Buy
20,657
+4,392
+27% +$357K 0.04% 371
2015
Q4
$1.45M Buy
16,265
+115
+0.7% +$9.77K 0.04% 429
2015
Q3
$1.24M Sell
16,150
-1,485
-8% -$124K 0.04% 460
2015
Q2
$1.48M Buy
17,635
+668
+4% +$59K 0.03% 607
2015
Q1
$1.53M Buy
16,967
+5,163
+44% +$444K 0.03% 675
2014
Q4
$953K Sell
11,804
-863
-7% -$68.2K 0.02% 891
2014
Q3
$949K Sell
12,667
-3,446
-21% -$251K 0.02% 865
2014
Q2
$1.1M Buy
16,113
+10,821
+204% +$737K 0.02% 767
2014
Q1
$370K Buy
5,292
+976
+23% +$67.9K 0.01% 1312
2013
Q4
$288K Sell
4,316
-1,355
-24% -$82.8K 0.01% 1455
2013
Q3
$296K Buy
+5,671
New +$288K 0.01% 1347

Other funds holding CAH

Janney Montgomery Scott's CAH Position: Q2 2026 in Review

Janney Montgomery Scott increased its Cardinal Health (CAH) stake by 4.7% in Q2 2026, buying an estimated $1.75M and bringing the position to 185,309 shares worth $44M. The position accounts for 0.09% of the portfolio, ranked #234.

Janney Montgomery Scott first reported a position in CAH in Q3 2013 and has held it in 50 quarters since. 1,500 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Janney Montgomery Scott held 185,309 shares of Cardinal Health worth $44M as of Q2 2026.
  • Janney Montgomery Scott bought 8,403 Cardinal Health shares in Q2 2026, an estimated $1.75M.
  • Cardinal Health made up 0.09% of Janney Montgomery Scott's portfolio in Q2 2026, its #234 holding.
  • Janney Montgomery Scott first reported a position in Cardinal Health in Q3 2013 and has held it in 50 quarters since.
  • 1,500 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Janney Montgomery Scott's 13F filing for Q2 2026, filed 5 Aug 2026.